Works matching IS 00071188 AND DT 2013 AND VI 168 AND IP 1

Results: 36

[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.

Published in:

2013

By:

Molinari S;
Camarda V;
Rizzi A;
Marzola G;
Salvadori S;
Marzola E;
Molinari P;
McDonald J;
Ko M;
Lambert D;
Calo' G;
Guerrini R;
Molinari, S;
Camarda, V;
Rizzi, A;
Marzola, G;
Salvadori, S;
Marzola, E;
Molinari, P;
McDonald, J

Publication type:

journal article

Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 129, doi. 10.1111/j.1476-5381.2012.02088.x

By:

Birrell, Mark A;
Maher, Sarah A;
Buckley, James;
Dale, Nicole;
Bonvini, Sara;
Raemdonck, Kristof;
PullEN, Nick;
Giembycz, Mark A;
Belvisi, Maria G

Publication type:

Article

Control of TMEM16A by INO-4995 and other inositolphosphates.

Published in:

2013

By:

Tian Y;
Schreiber R;
Wanitchakool P;
Kongsuphol P;
Sousa M;
Uliyakina I;
Palma M;
Faria D;
Traynor-Kaplan AE;
Fragata JI;
Amaral MD;
Kunzelmann K;
Tian, Yuemin;
Schreiber, Rainer;
Wanitchakool, Podchanart;
Kongsuphol, Patthara;
Sousa, Marisa;
Uliyakina, Inna;
Palma, Marta;
Faria, Diana

Publication type:

journal article

EO9 (Apaziquone): from the clinic to the laboratory and back again.

Published in:

2013

By:

Phillips RM;
Hendriks HR;
Peters GJ;
EORTC-Pharmacology and Molecular Mechanism Group;
Phillips, Roger M;
Hendriks, Hans R;
Peters, Godefridus J

Publication type:

journal article

Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway.

Published in:

2013

By:

Turpin E;
Muscat A;
Vatier C;
Chetrite G;
Corruble E;
Moldes M;
Fève B;
Turpin, E;
Muscat, A;
Vatier, C;
Chetrite, G;
Corruble, E;
Moldes, M;
Fève, B

Publication type:

journal article

Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26).

Published in:

2013

By:

Qin C;
Buxton KD;
Pepe S;
Cao AH;
Venardos K;
Love JE;
Kaye DM;
Yang YH;
Morand EF;
Ritchie RH;
Qin, Chengxue;
Buxton, Keith D;
Pepe, Salvatore;
Cao, Anh H;
Venardos, Kylie;
Love, Jane E;
Kaye, David M;
Yang, Yuan H;
Morand, Eric F;
Ritchie, Rebecca H

Publication type:

journal article

The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 212, doi. 10.1111/j.1476-5381.2012.02130.x

By:

Vara, D;
Campanella, M;
Pula, G

Publication type:

Article

Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 189, doi. 10.1111/j.1476-5381.2012.02123.x

By:

Chattong, S;
Tanamai, J;
Kiatsomchai, P;
Nakatsu, M;
Sereemaspun, A;
Pimpha, N;
Praditpornsilpa, K;
Rojanathanes, R;
Sethpakadee, A;
Tungsanga, K;
Eiam ‐ Ong, S;
Manotham, K

Publication type:

Article

Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.

Published in:

2013

By:

Yu SS;
Cai Y;
Ye JT;
Pi RB;
Chen SR;
Liu PQ;
Shen XY;
Ji Y;
Yu, Shan-Shan;
Cai, Yi;
Ye, Jian-Tao;
Pi, Rong-Biao;
Chen, Shao-Rui;
Liu, Pei-Qing;
Shen, Xiao-Yan;
Ji, Yong

Publication type:

journal article

Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

Published in:

2013

By:

De Petrocellis L;
Ligresti A;
Schiano Moriello A;
Iappelli M;
Verde R;
Stott CG;
Cristino L;
Orlando P;
Di Marzo V;
De Petrocellis, Luciano;
Ligresti, Alessia;
Schiano Moriello, Aniello;
Iappelli, Mariagrazia;
Verde, Roberta;
Stott, Colin G;
Cristino, Luigia;
Orlando, Pierangelo;
Di Marzo, Vincenzo

Publication type:

journal article

Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor.

Published in:

2013

By:

Birrell MA;
Maher SA;
Buckley J;
Dale N;
Bonvini S;
Raemdonck K;
Pullen N;
Giembycz MA;
Belvisi MG;
Birrell, Mark A;
Maher, Sarah A;
Buckley, James;
Dale, Nicole;
Bonvini, Sara;
Raemdonck, Kristof;
Pullen, Nick;
Giembycz, Mark A;
Belvisi, Maria G

Publication type:

journal article

Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin- A1 and its N-terminal-derived peptide Ac- ANX- A12-26.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 238, doi. 10.1111/j.1476-5381.2012.02176.x

By:

Qin, Chengxue;
Buxton, Keith D;
Pepe, Salvatore;
Cao, Anh H;
Venardos, Kylie;
Love, Jane E;
Kaye, David M;
Yang, Yuan H;
Morand, Eric F;
Ritchie, Rebecca H

Publication type:

Article

Translational neuropharmacology: the use of human isolated gastrointestinal tissues.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 28, doi. 10.1111/j.1476-5381.2012.02198.x

By:

Sanger, GJ;
Broad, J;
Kung, V;
Knowles, CH

Publication type:

Article

EO9 (Apaziquone): from the clinic to the laboratory and back again.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 11, doi. 10.1111/j.1476-5381.2012.01996.x

By:

Phillips, Roger M;
HENdriks, Hans R;
Peters, Godefridus J

Publication type:

Article

BJP goes online after 66 years on paper.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 1, doi. 10.1111/bph.12078

By:

McGrath, John C

Publication type:

Article

Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 103, doi. 10.1111/j.1476-5381.2012.01850.x

By:

NguyEN, Hai T;
Guiard, Bruno P;
Bacq, Alexandre;
David, DENis J;
David, Indira;
Quesseveur, Gaël;
Gautron, Sophie;
Sanchez, Connie;
Gardier, Alain M

Publication type:

Article

Control of TMEM16A by INO-4995 and other inositolphosphates.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 253, doi. 10.1111/j.1476-5381.2012.02193.x

By:

Tian, Yuemin;
Schreiber, Rainer;
Wanitchakool, Podchanart;
Kongsuphol, Patthara;
Sousa, Marisa;
Uliyakina, Inna;
Palma, Marta;
Faria, Diana;
Traynor ‐ Kaplan, Alexis E;
Fragata, José I;
Amaral, Margarida D;
Kunzelmann, Karl

Publication type:

Article

Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 225, doi. 10.1111/j.1476-5381.2012.02128.x

By:

Cipriani, Sabrina;
Mencarelli, Andrea;
Bruno, Angela;
Renga, Barbara;
Distrutti, Eleonora;
Santucci, Luca;
Baldelli, Franco;
Fiorucci, Stefano

Publication type:

Article

Inhibition of Yersinia pestis DNA adenine methyltransferase in vitro by a stibonic acid compound: identification of a potential novel class of antimicrobial agents.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 172, doi. 10.1111/j.1476-5381.2012.02134.x

By:

McKelvie, JC;
Richards, MI;
Harmer, JE;
Milne, TS;
Roach, PL;
Oyston, PCF

Publication type:

Article

Corrigendum.

Published in:: 2013
Publication type:: Erratum

Paraquat research: do recent advances in limiting its toxicity make its use safer?

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 44, doi. 10.1111/j.1476-5381.2012.02017.x

By:

Baltazar, Teresa;
Dinis ‐ Oliveira, Ricardo Jorge;
Duarte, José Alberto;
de Lourdes Bastos, Maria;
Carvalho, Félix

Publication type:

Article

Not different is not the same as the same: how can we tell?

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 7, doi. 10.1111/j.1476-5381.2012.02210.x

By:

Drummond, Gordon B;
Vowler, Sarah L

Publication type:

Article

Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 139, doi. 10.1111/j.1476-5381.2012.02140.x

By:

Turpin, E;
Muscat, A;
Vatier, C;
Chetrite, G;
Corruble, E;
Moldes, M;
Fève, B

Publication type:

Article

Autophagy, mitochondria and 3-nitropropionic acid joined in the same model.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 60, doi. 10.1111/j.1476-5381.2012.02203.x

By:

González ‐ Polo, Rosa A;
Bravo ‐ San Pedro, José M;
Gómez ‐ Sánchez, Rubén;
Pizarro ‐ Estrella, Elisa;
Niso ‐ Santano, Mireia;
Fuentes, José M

Publication type:

Article

Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 266, doi. 10.1111/j.1476-5381.2012.02180.x

By:

Fogli, S;
Stefanelli, F;
Picchianti, L;
Del Re, M;
Mey, V;
Bardelli, C;
Danesi, R;
Breschi, MC

Publication type:

Article

The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 46, doi. 10.1111/j.1476-5381.2012.01870.x

By:

Janda, Elzbieta;
Parafati, MaddalENa;
Aprigliano, Serafina;
Carresi, Cristina;
Visalli, Valeria;
Sacco, Iolanda;
VENtrice, DomENica;
Mega, Tiziana;
Vadalá, Nuria;
Rinaldi, Stefano;
Musolino, VincENzo;
Palma, Ernesto;
Gratteri, Santo;
Rotiroti, DomENicantonio;
Mollace, VincENzo

Publication type:

Article

One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 19, doi. 10.1111/j.1476-5381.2012.02133.x

By:

Jepps, TA;
OlesEN, SP;
GreENwood, IA

Publication type:

Article

Protein engineering and preclinical development of a GM- CSF receptor antibody for the treatment of rheumatoid arthritis.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 200, doi. 10.1111/j.1476-5381.2012.02173.x

By:

Minter, RR;
Cohen, ES;
Wang, B;
Liang, M;
Vainshtein, I;
Rees, G;
Eghobamien, L;
Harrison, P;
Sims, DA;
Matthews, C;
Wilkinson, T;
Monk, P;
Drinkwater, C;
Fabri, L;
Nash, A;
McCourt, M;
Jermutus, L;
Roskos, L;
Anderson, IK;
Sleeman, MA

Publication type:

Article

[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 151, doi. 10.1111/j.1476-5381.2012.02115.x

By:

Molinari, S;
Camarda, V;
Rizzi, A;
Marzola, G;
Salvadori, S;
Marzola, E;
Molinari, P;
McDonald, J;
Ko, MC;
Lambert, DG;
Calo', G;
Guerrini, R

Publication type:

Article

Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 79, doi. 10.1111/j.1476-5381.2012.02027.x

By:

De Petrocellis, Luciano;
Ligresti, Alessia;
Schiano Moriello, Aniello;
Iappelli, Mariagrazia;
Verde, Roberta;
Stott, Colin G;
Cristino, Luigia;
Orlando, Pierangelo;
Di Marzo, VincENzo

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2013, v. 168, n. 1, p. i, doi. 10.1111/j.1476-5381.2012.02148.x
Publication type:: Article

The autophagic inhibitor 3-methyladenine potently stimulates PKA-dependent lipolysis in adipocytes.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 163, doi. 10.1111/j.1476-5381.2012.02110.x

By:

Heckmann, Bradlee L;
Yang, Xingyuan;
Zhang, Xiaodong;
Liu, Jun

Publication type:

Article

Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 117, doi. 10.1111/j.1476-5381.2012.01903.x

By:

Yu, Shan ‐ Shan;
Cai, Yi;
Ye, Jian ‐ Tao;
Pi, Rong ‐ Biao;
ChEN, Shao ‐ Rui;
Liu, Pei ‐ Qing;
ShEN, Xiao ‐ Yan;
Ji, Yong

Publication type:

Article

Towards the use of non-psychoactive cannabinoids for prostate cancer.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 76, doi. 10.1111/j.1476-5381.2012.02121.x

By:

Pacher, Pál

Publication type:

Article

Type I: families, planning and errors.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 2, doi. 10.1111/j.1476-5381.2012.02206.x

By:

Drummond, Gordon B;
Vowler, Sarah L

Publication type:

Article

3-Nitropropionic acid induces autophagy by forming mitochondrial permeability transition pores rather than activatiing the mitochondrial fission pathway.

Published in:

British Journal of Pharmacology, 2013, v. 168, n. 1, p. 63, doi. 10.1111/j.1476-5381.2012.01994.x

By:

Solesio, Maria E;
Saez ‐ AtiENzar, Sara;
Jordan, Joaquin;
Galindo, Maria F

Publication type:

Article

Works matching IS 00071188 AND DT 2013 AND VI 168 AND IP 1

[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.

Selectivity profiling of the novel EP<sub>2</sub> receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP<sub>2</sub> receptor.

Control of TMEM16A by INO-4995 and other inositolphosphates.

EO9 (Apaziquone): from the clinic to the laboratory and back again.

Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway.

Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26).

The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.

Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production.

Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.

Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor.

Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin- A1 and its N-terminal-derived peptide Ac- ANX- A1<sub>2-26</sub>.

Translational neuropharmacology: the use of human isolated gastrointestinal tissues.

EO9 (Apaziquone): from the clinic to the laboratory and back again.

BJP goes online after 66 years on paper.

Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.

Control of TMEM16A by INO-4995 and other inositolphosphates.

Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice.

Inhibition of Yersinia pestis DNA adenine methyltransferase in vitro by a stibonic acid compound: identification of a potential novel class of antimicrobial agents.

Corrigendum.

Paraquat research: do recent advances in limiting its toxicity make its use safer?

Not different is not the same as the same: how can we tell?

Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway.

Autophagy, mitochondria and 3-nitropropionic acid joined in the same model.

Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation.

The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo.

One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders.

Protein engineering and preclinical development of a GM- CSF receptor antibody for the treatment of rheumatoid arthritis.

[Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub>: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.

Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

Issue Information.

The autophagic inhibitor 3-methyladenine potently stimulates PKA-dependent lipolysis in adipocytes.

Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.

Towards the use of non-psychoactive cannabinoids for prostate cancer.

Type I: families, planning and errors.

3-Nitropropionic acid induces autophagy by forming mitochondrial permeability transition pores rather than activatiing the mitochondrial fission pathway.